Literature DB >> 25930247

Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.

Shoshana M Rosenberg1, Karen Sepucha2, Kathryn J Ruddy3, Rulla M Tamimi4, Shari Gelber5, Meghan E Meyer1, Lidia Schapira2, Steven E Come6, Virginia F Borges7, Mehra Golshan8, Eric P Winer1, Ann H Partridge9.   

Abstract

BACKGROUND: Rates of contralateral prophylactic mastectomy (CPM) have increased in the United States, with younger women with breast cancer the most likely to have CPM.
METHODS: As part of an ongoing cohort study of young women diagnosed with breast cancer at age ≤40 years, we conducted multinomial logistic regression of data from 560 women with unilateral Stage I-III disease to identify factors associated with: (1) CPM versus unilateral mastectomy (UM); (2) CPM versus breast-conserving surgery (BCS).
RESULTS: Median age at diagnosis was 37 years; 66 % of women indicated that their doctor said that BCS was an option or was recommended. Of all women, 42.9 % had CPM, 26.8 % UM, and 30.4 % BCS. Among women who said the surgical decision was patient-driven, 59.9 % had CPM, 22.8 % BCS, and 17.3 % UM. Clinical characteristics associated with CPM versus BCS included HER2 positivity, nodal involvement, larger tumor size, lower BMI, parity, and testing positive for a BRCA mutation. Emotional and decisional factors associated with CPM versus UM and BCS included anxiety, less fear of recurrence, and reporting a patient-driven decision. Women who reported a physician-driven decision were less likely to have had CPM than both of the other surgeries, whereas higher confidence with the decision was associated with having CPM versus BCS.
CONCLUSIONS: Many young women with early-stage breast cancer are choosing CPM. The association between CPM and emotional and decisional factors suggest that improved communication together with better psychosocial support may improve the decision-making process.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25930247      PMCID: PMC4598267          DOI: 10.1245/s10434-015-4572-6

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  36 in total

1.  Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.

Authors:  Sarah T Hawley; Reshma Jagsi; Monica Morrow; Nancy K Janz; Ann Hamilton; John J Graff; Steven J Katz
Journal:  JAMA Surg       Date:  2014-06       Impact factor: 14.766

2.  Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.

Authors:  Marissa Howard-McNatt; Rebecca W Schroll; Gail J Hurt; Edward A Levine
Journal:  Am J Surg       Date:  2011-09       Impact factor: 2.565

3.  Nationwide trends in mastectomy for early-stage breast cancer.

Authors:  Kristy L Kummerow; Liping Du; David F Penson; Yu Shyr; Mary A Hooks
Journal:  JAMA Surg       Date:  2015-01       Impact factor: 14.766

4.  Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: a cross-sectional survey.

Authors:  Shoshana M Rosenberg; Michaela S Tracy; Meghan E Meyer; Karen Sepucha; Shari Gelber; Judi Hirshfield-Bartek; Susan Troyan; Monica Morrow; Lidia Schapira; Steven E Come; Eric P Winer; Ann H Partridge
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

5.  Complications and morbidity following breast reconstruction--a review of 16,063 cases from the 2005-2010 NSQIP datasets.

Authors:  John P Fischer; Jonas A Nelson; Alexander Au; C T Tuggle; Joseph M Serletti; Liza C Wu
Journal:  J Plast Surg Hand Surg       Date:  2013-07-18

6.  Operative risks associated with contralateral prophylactic mastectomy: a single institution experience.

Authors:  Megan E Miller; Tomasz Czechura; Brigid Martz; Mary E Hall; Catherine Pesce; Nora Jaskowiak; David J Winchester; Katharine Yao
Journal:  Ann Surg Oncol       Date:  2013-07-19       Impact factor: 5.344

7.  Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.

Authors:  Pamela R Portschy; Karen M Kuntz; Todd M Tuttle
Journal:  J Natl Cancer Inst       Date:  2014-07-16       Impact factor: 13.506

8.  Impact of bilateral versus unilateral mastectomy on short term outcomes and adjuvant therapy, 2003-2010: a report from the National Cancer Data Base.

Authors:  Susan M Sharpe; Erik Liederbach; Tomasz Czechura; Catherine Pesce; David J Winchester; Katharine Yao
Journal:  Ann Surg Oncol       Date:  2014-04-12       Impact factor: 5.344

Review 9.  Contralateral risk-reducing mastectomy in sporadic breast cancer.

Authors:  John A Murphy; Thomas D Milner; Joseph M O'Donoghue
Journal:  Lancet Oncol       Date:  2013-06       Impact factor: 41.316

10.  Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database.

Authors:  Fahima Osman; Fady Saleh; Timothy D Jackson; Mark A Corrigan; Tulin Cil
Journal:  Ann Surg Oncol       Date:  2013-07-12       Impact factor: 5.344

View more
  34 in total

1.  Impact of Unilateral versus Bilateral Breast Reconstruction on Procedure Choices and Outcomes.

Authors:  Erin M Taylor; Edwin G Wilkins; Andrea L Pusic; Ji Qi; Hyungjin Myra Kim; Jennifer B Hamill; Gretchen E Guldbrandsen; Yoon S Chun
Journal:  Plast Reconstr Surg       Date:  2019-06       Impact factor: 4.730

2.  Surgical Management of Lobular Carcinoma In Situ: Analysis of the National Cancer Database.

Authors:  Lauren J Taylor; Jennifer Steiman; Jessica R Schumacher; Lee G Wilke; Caprice C Greenberg; Heather B Neuman
Journal:  Ann Surg Oncol       Date:  2018-05-31       Impact factor: 5.344

3.  Tradeoffs Associated With Contralateral Prophylactic Mastectomy in Women Choosing Breast Reconstruction: Results of a Prospective Multicenter Cohort.

Authors:  Adeyiza O Momoh; Wess A Cohen; Kelley M Kidwell; Jennifer B Hamill; Ji Qi; Andrea L Pusic; Edwin G Wilkins; Evan Matros
Journal:  Ann Surg       Date:  2017-07       Impact factor: 12.969

4.  Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.

Authors:  Thomas A D'Agostino; Abenaa M Brewster; Susan K Peterson; Isabelle Bedrosian; Patricia A Parker
Journal:  Transl Behav Med       Date:  2020-05-20       Impact factor: 3.046

5.  Surgical treatment choices for breast cancer in Newfoundland and Labrador: a retrospective cohort study.

Authors:  Farah McCrate; Elizabeth Dicks; Erin Powell; Joanne Chafe; Rebecca Roome; Charlene Simmonds; Holly Etchegary
Journal:  Can J Surg       Date:  2018-12-01       Impact factor: 2.089

6.  What drives variation in spending for breast cancer patients within geographic regions?

Authors:  Anna D Sinaiko; Alyna T Chien; Michael J Hassett; Pragya Kakani; Danielle Rodin; David J Meyers; Belen Fraile; Meredith B Rosenthal; Mary Beth Landrum
Journal:  Health Serv Res       Date:  2018-10-14       Impact factor: 3.402

7.  Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives.

Authors:  E Dicks; R Roome; J Chafe; E Powell; F McCrate; C Simmonds; H Etchegary
Journal:  Curr Oncol       Date:  2019-04-01       Impact factor: 3.677

8.  Patient-reported outcomes among women with unilateral breast cancer undergoing breast conservation versus single or double mastectomy.

Authors:  Catherine Pesce; Jennifer Jaffe; Kristine Kuchta; Katharine Yao; Mark Sisco
Journal:  Breast Cancer Res Treat       Date:  2020-10-08       Impact factor: 4.872

9.  Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and Outcomes.

Authors:  Jinani Jayasekera; Susan T Vadaparampil; Susan Eggly; Richard L Street; Tanina Foster Moore; Claudine Isaacs; Hyo S Han; Bianca Augusto; Jennifer Garcia; Katherine Lopez; Suzanne C O'Neill
Journal:  JCO Oncol Pract       Date:  2020-05-28

10.  Considerations arising from requests from patients for a bilateral mastectomy who are eligible for breast-conserving surgery: Factors weighing for and against performing the operation.

Authors:  Alessandro Fancellu
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.